Anifrolumab (Saphnelo) listed in SK
May 1, 2024 – Lupus Canada is pleased to share that Lupus Awareness Month is kicking off with a Saphnelo listing in Saskatchewan effective May 1st, 2024. With this listing, Saphnelo is now covered by 86% of Canadian public drug reimbursement plans.
For more information, you can visit the Saskatchewan Drug Plan website and enter ‘anifrolumab’ into the search bar or view the May Saskatchewan Formulary Bulletin.